Resilient Biotics Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Mezzanine

  • Latest Deal Amount
  • $1.5M

  • Investors
  • 9

Resilient Biotics General Information

Description

Developer of non-antibiotic, microbiome-based therapeutics designed to combat complex respiratory infections with applications in human and animal health. The company utilizes a proprietary discovery platform that incorporates high-resolution genomic analyses, in-house machine learning algorithms, and targeted in vitro assays to identify naturally occurring microbiome-derived strains that have immune activation and pathogen inhibition properties in respiratory tissues, enabling the animal and healthcare industry with more effective treatment strategies while reducing dependency on antibiotics.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2 Davis Drive
  • Durham, NC 27709
  • United States
+1 (717)
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • 2 Davis Drive
  • Durham, NC 27709
  • United States
+1 (717)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Resilient Biotics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Mezzanine 12-Dec-2024 $1.5M Completed Generating Revenue
6. Later Stage VC 18-Aug-2022 Completed Generating Revenue
5. Grant 25-Mar-2021 Completed Clinical Trials - General
4. Early Stage VC (Series A) 09-Dec-2020 Completed Clinical Trials - General
3. Accelerator/Incubator 01-Jan-2019 Completed Clinical Trials - General
2. Accelerator/Incubator 25-Jul-2017 $20K $20K Completed Startup
1. Accelerator/Incubator Completed Startup
To view Resilient Biotics’s complete valuation and funding history, request access »

Resilient Biotics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-3
Series A-2
Series A-1 10,909,702 $0.000100 $0.6 $0.6 1x $0.6 25.74%
To view Resilient Biotics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Resilient Biotics Patents

Resilient Biotics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20180137243-A1 Therapeutic methods using metagenomic data from microbial communities Inactive 17-Nov-2016

Resilient Biotics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Resilient Biotics Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
ARCH Venture Partners Venture Capital Minority
Beef Alliance Corporation
Elanco Animal Health Corporation Minority
Fulcrum Global Capital Venture Capital Minority
iiM (Merriam) Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Resilient Biotics FAQs

  • When was Resilient Biotics founded?

    Resilient Biotics was founded in 2016.

  • Where is Resilient Biotics headquartered?

    Resilient Biotics is headquartered in Durham, NC.

  • What is the size of Resilient Biotics?

    Resilient Biotics has 5 total employees.

  • What industry is Resilient Biotics in?

    Resilient Biotics’s primary industry is Drug Discovery.

  • Is Resilient Biotics a private or public company?

    Resilient Biotics is a Private company.

  • What is Resilient Biotics’s current revenue?

    The current revenue for Resilient Biotics is .

  • How much funding has Resilient Biotics raised over time?

    Resilient Biotics has raised $11.1M.

  • Who are Resilient Biotics’s investors?

    ARCH Venture Partners, Beef Alliance, Elanco Animal Health, Fulcrum Global Capital, and iiM (Merriam) are 5 of 9 investors who have invested in Resilient Biotics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process